Luitpold Pharmaceuticals — Norristown, Pennsylvania

Luitpold Pharmaceuticals is a clinical research site located in Norristown, Pennsylvania, United States 19403.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

Luitpold Pharmaceuticals has participated in 20 clinical trials.

Therapeutic areas: Anemia, Iron Deficiency Anemia, Impaired Renal Function.

Sponsors: American Regent, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Norristown

Browse all research sites in Pennsylvania · View every site in Norristown

• Mercy Suburban Hospital and Cancer Center
• Suburban Community Hospital and Cancer Center
• Keystone Clinical Studies
• Novo Nordisk Investigational Site
• Research Site
• Pearl Clinical Research
• Pfizer Investigational Site
• Local Institution
• GSK Investigational Site
• US1124
• Dr. Cherian Verghese

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Luitpold Pharmaceuticals?

Luitpold Pharmaceuticals has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Luitpold Pharmaceuticals conducted?

Luitpold Pharmaceuticals has 20 clinical trials on record. Their work covers Anemia, Iron Deficiency Anemia, Impaired Renal Function.

Is Luitpold Pharmaceuticals accredited by Crixeo Clinical Trials?

Luitpold Pharmaceuticals has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Luitpold Pharmaceuticals?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.